Press Releases

January 21 2016

BVGH engages leading biopharmaceutical companies in partnerships and programs to address...

June 6 2012

The report will be released at a Super Session, titled "International Leaders Share Their...

February 21 2011

The Biotechnology Industry Organization (BIO) stresses the critical importance of protecting...

April 6 2010

The Obama Administration has made substantial progress to avoid retaliatory measures in a long...

March 2 2010

The Biotechnology Industry Organization (BIO) applauded today’s announcement by the...

Letters, Testimony & Comments

February 8 2016
The Biotechnology Innovation Organization (BIO) appreciates the opportunity to comment on the 2016 Special 301 Submission. 
December 15 2015
The Biotechnology Industry Organization (BIO) greatly appreciates the opportunity to provide comments/suggestions of the stakeholders on the Draft Patents (Amendment) Rules 2015 published by the Ministry of Commerce & Industry.
February 9 2015
The Biotechnology Industry Organization (BIO) appreciates the opportunity to participate in the Special 301 process and is hopeful that our contribution will assist the United States Trade Representative’s (USTR) efforts in preserving strong intellectual property protections for United States’ companies internationally. BIO appreciates the opportunity to comment on 2015 Special 301 Review: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment and Announcement of Public Hearing.
July 10 2013
Therapeutic biologics are an opportunity to address unmet patient needs, drive innovation, and assist China's transformation into a knowledge-intensive economy.
June 19 2013
The TTIP represents a profoundly important opportunity to advance progress in these areas. The following comments represent BIO’s initial suggestions for the formulation of negotiating objectives relevant to biotechnology.  

Press Releases

April 28 2016
BIO commends the USTR and the Special 301 Interagency Committee for engaging U.S. innovators as they seek to improve global intellectual property standards and enforcement, and to promote pro-innovative environments in countries around the world.
January 21 2016
BVGH engages leading biopharmaceutical companies in partnerships and programs to address challenging global health issues
July 29 2015
Today BIO joined a coalition of organizations urging the Government of Japan to maintain the established reimbursement pricing structure for pharmaceuticals and medical devices.
June 20 2012
The Biotechnology Industry Organization(BIO) unveiled a report on the role of intellectual property rights in encouraging upstream research and development as well as downstream commercialization of biotechnology at the 2012 BIO International Convention.
June 6 2012
The report will be released at a Super Session, titled "International Leaders Share Their Worldview: Scientific American's Regional Bio-Innovation Scorecard."